news 2020

Researchers at Heidelberg University have formed an alliance - the fightCOVID @ Heidelberg research and development task force - with the aim to curb the coronavirus pandemic. To this end, scientists of the two Medical Faculties and the Heidelberg and Mannheim University Hospitals, the BioQuant centre, the Center for Molecular Biology and the Central Institute of Mental Health in Mannheim have joined forces with colleagues from the German Cancer Research Center (DKFZ) and the European Molecular Biology Laboratory (EMBL) in Heidelberg.

Clinical trials on Covid-19 at university hospital TUM Klinikum rechts der Isar The university hospital is participating in studies on new medications for people suffering from Covid-19. As part of a clinical study, patients can be treated with medications that are still under development. 50 patients infected with the novel Coronavirus are currently being treated at the university hospital TUM Klinikum rechts der Isar.

Therapeutic vaccination may help to cure chronic hepatitis B infection Researchers at Technical University of Munich (TUM), Helmholtz Zentrum München and the German Center for Infection Research (DZIF) have developed a novel therapeutic approach to cure chronic hepatitis B. The scientists found that the large amount of hepatitis B virus proteins expressed in the liver prevents the body's immune system to defeat the virus.

Freie Universität Berlin participates in international research project to develop new therapies against antibiotic-resistant pathogens of pneumonia / Funded with 10 million euros from the European Union No 025/2020 from Feb 04, 2020 Scientists from eleven European research institutions, including the Institute of Pharmacy at Freie Universität Berlin, are jointly looking for new ways to combat antibiotic-resistant pathogens.